Dr. Steven presents in the Philippines
Dr. Steven presented at the Philippine Society of Allergy, Asthma & Immunology conference in Manila.
Dr. Steven visits Capitol Hill
Dr. Steven traveled to Washington, DC again this year for Allergy & Asthma Action Day on Capitol Hill to advocate for patients with allergies and asthma.
Health Disparities and World Health Day
There are important health disparities right here in southeastern Wisconsin, and the Allergy, Asthma & Sinus Center would like to help.
Symjepi: A new option for injectable epinephrine
The FDA has approved Symjepi, a new device for injectable epinephrine. Patients now have an additional option when choosing an epinephrine injector with their allergist.
Wixela: Generic version of Advair now approved
The FDA has approved Wixela, a generic form of the Advair inhaler. With this generic, we will hopefully see some of the price relief we need in the treatment of asthma!
FDA approves Primatene Mist
The Food and Drug Administration approved Primatene Mist for over-the-counter status. Allergists across the country are voicing their concerns about this decision.
FDA alerts patients with EpiPens
The Food and Drug Administration alerts patients and providers that the labels on certain auto injectors may prevent easily removing the device from its carrier tube.
Publication: Shared decision making for the allergist
Dr. Steven was the second author on a publication in the October 2018 Annals of Allergy, Asthma & Immunology for his contributions to the new shared decision making tool.
WANT TO READ EVEN MORE NEWS ARTICLES?
Visit the Allergy, Asthma & Sinus Center news archive to see all of our news items from the last two years.
